Nathan Pennell, MD, Ph.D., GRACE Faculty

Nathan Pennell, MD, Ph.D. Medical Oncology, Internal Medicine
Taussig Cancer Center
Cleveland
OH
Specialties
Lung cancer, mesothelioma, and thyroid cancer

Dr. Nathan Pennell received his Ph.D. in neuroscience in 1998 and his M.D. in 2002 from the University of Florida College of Medicine in Gainesville, FL. He then moved to Boston to do his internal medicine internship and residency training at Brigham & Women’s Hospital, and completed his medical oncology fellowship at the Dana Farber Cancer Institute, also in Boston. While there, he developed an expertise in lung cancer, mesothelioma, and thyroid cancer. He moved to the friendly midwest in 2008 to continue with this focus at the Taussig Cancer Institute at the Cleveland Clinic.

Dr. Pennell specializes in the treatment of thoracic malignancies with a focus on lung cancer. His research interests include clinical trials using novel therapies, with a goal of facilitating the movement of new treatments from the laboratory to the clinic. GRACE is pleased to welcome Dr. Pennell as a faculty member.

Conflict of Interest

None

From the GRACE Archives - Originally Published August 26, 2009 | By Dr Pennell 

OK, I hope you all aren’t bored to tears by this topic by now, given two related posts in April and again earlier this month describing the “broken” clinical trials system and the challenges to performing clinical research in the current environment. However, I thought this would be a good follow up post to let all of you know that the laughably obstructionist policies in place that prevent timely processing of clinical trials are being recognized, and that something is being done to fix it.

From the GRACE Archives - Originally Published April 11, 2009 | By Dr Pennell 

Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses new options in acquired resistance for ALK positive non-small cell lung cancer (NSCLC).

Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses the role for immunotherapy in patients with a driver mutation.

Forum Discussions

Original post date: 2022-02-21

Hi all -- share your cancer journey here and connect with others.  Cancer.gov has a good general description of Cholangiocarcinoma.  This rare disease has support information and programs that can be

Last Activity: Mon, 02/21/2022 - 11:15
Original post date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 

Last Activity: Sat, 02/05/2022 - 12:12
Original post date: 2022-02-01

Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder.  Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the

Last Activity: Tue, 02/01/2022 - 16:16
Original post date: 2021-11-24

The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!

Image
Happy Thanksgiving!
Last Activity: Thu, 12/02/2021 - 15:33
Original post date: 2021-01-07
The research team at Tulane University is conducting an online survey of individuals with cancer. 

GRACE has been asked to share information about an anonymous one-time online research study about

Last Activity: Thu, 01/07/2021 - 15:55

Comments

Post Date: 2022-04-12

You may find our clinical trial page helpful, also.  https://cancergrace.org/find-clinical-trials.  

Post Date: 2022-02-04

Keep your eye out for new Head and Neck information soon! 


This comment has been promoted to its

Post Date: 2021-12-02

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that

Post Date: 2021-07-19

Hi all!  

The 2021 Targeted Therapies Patient Forum is now available ON Demand!  

Click below to